Prachi Umbarkar

8PUBLICATIONS
30CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Cardiology (incl. cardiovascular diseases)PharmacogenomicsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 01, 2026
Osimertinib-induced cardiotoxicity is driven by HDAC-dependent epigenetic repression and rescued by vorinostat.

|Sep 30, 2024
Animal models of haploinsufficiency revealed the isoform-specific role of GSK-3 in HFD-induced obesity and glucose intolerance.

Manisha Gupte, Prachi Umbarkar, Jacob Lemon

|Sep 26, 2023
Sustained Increases in Cardiomyocyte Protein O-Linked β-N-Acetylglucosamine Levels Lead to Cardiac Hypertrophy and Reduced Mitochondrial Function Without Systolic Contractile Impairment.

Chae-Myeong Ha, Sayan Bakshi, Manoja K Brahma

|Jan 10, 2023
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation.

Sultan Tousif, Anand P Singh, Prachi Umbarkar

|Sep 02, 2022
Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.

Prachi Umbarkar, Sultan Tousif, Anand P Singh

|Feb 15, 2022
Isoform-Specific Role of GSK-3 in High Fat Diet Induced Obesity and Glucose Intolerance.

Manisha Gupte, Sultan Tousif, Jacob J Lemon

Pageof 2

Frequent Collaborators

5 joint publications

Hind Lal

3 joint publications

Anand Prakash Singh

1 joint publications

Frank J Raucci

1 joint publications

Wejdan Aljafar